S1471

TRENTON – Senator Barbara Buono, sponsor of S-1471, the bill to provide $270 million in funding to build stem cell research centers and facilities for cancer and biomedical research in New Jersey, made the following statement today following the signing of the bill by Governor Corzine:

“Today we have taken the next step in creating a legacy for New Jersey of hope, compassion, and discovery based on the promise of stem cell research.

TRENTON – In a move that could position New Jersey as a leader in stem cell research, both houses of the legislature gave final approval to a bill sponsored by Senate President Richard J. Codey (D-Essex) to fund a world-class stem cell institute and several other supporting research facilities throughout the state.

“This is a long-term investment in our natural assets that may one day yield life altering results for New Jersey residents and people the world over,” said Sen. Codey. “New Jersey’s stem cell institute can be the place where hope translates into real therapies. This bill has the potential to secure New Jersey’s place as a leader in the life science industry, ease suffering and save countless lives.”

TRENTON – New Jersey’s stem cell agenda moved forward with resounding approval today as the full Senate voted 29 to 10 to approve S-1471, a bill sponsored by Senate President Richard J. Codey, D-Essex, which would allocate funding to build a world-class stem cell institute. The legislation, which is co-sponsored by Sen. Barbara Buono, D-Middlesex, allocates $250 million in unused bond capacity for construction of a $150 million stem cell institute in New Brunswick, a $50 million joint biomedical research facility in Camden, and a $50 million adult stem cell research facility at the New Jersey Institute of Technology (NJIT) in Newark.

“New Jersey’s stem cell institute can be the place where hope translates into real therapies,” said Sen. Codey. “New Jersey has a lot of advantages in the race for a cure, with our first rate universities and some of the world’s leading pharmaceutical and bio-tech companies. This bill has the potential to secure New Jersey’s place as a leader in the life science industry, ease suffering and save countless lives. But, right now there are only a handful of first-rate stem cell scientists and they are waiting on the edge of their seat to see who makes the first serious investment. Every day we wait potentially puts us a day behind.”

TRENTON – Senator Barbara Buono, D-Middlesex, made the follow statement today after the Senate passed her bill, S-1471, which would authorize $250 million to build stem cell research and biomedical research facilities in New Jersey:

“”New Jersey is a global leader in developing advanced medical cures that save countless lives. The stem cell research centers will allow us to maintain this lead while working with researchers from around the world to realize the potential that stem cell research has. For those living with diabetes, Parkinson’s disease, cancer or numerous other diseases, the stem cell research centers will be a symbol of hope.

TRENTON – New Jersey’s stem cell agenda took another step forward today with the Senate Budget Committee approving a bill sponsored by Senate President Richard J. Codey, D-Essex, which allocates $150 million to build a world-class stem cell institute. Sen. Codey testified before the committee, saying the bill, S1471, “has the potential to chart a new course in New Jersey history and the history of medical treatment all over the world.”

The legislation, which is co-sponsored by Sen. Barbara Buono, D-Middlesex, allocates $200 million in unused bond capacity for construction of a stem cell institute in New Brunswick, as well as $50 million for a joint biomedical research facility in Camden. The stem cell institute would be located in the heart of New Jersey’s world-renowned life sciences industry and would be jointly operated by Rutgers University and the UMDNJ-Robert Wood Johnson Medical School.

TRENTON – Senate President Richard J. Codey, D-Essex, today continued his pledge to advance New Jersey’s stem cell research agenda by introducing legislation allocating $150 million in unused bond capacity for construction of a world-class stem cell research facility.

“Every moment we delay funding New Jersey’s Stem Cell Institute will cost us, both in lives lost and economic potential unrealized. New research shows stem cells may be the key to fighting cancer. In New Jersey, alone, think about how many lives could be saved by these therapies, and how much suffering could be eased,” said Sen. Codey. “This new facility will provide patients throughout our state with easy access to the most cutting-edge treatments and best possible care. I look forward to working with Governor Corzine, Speaker Roberts and stem cell supporters like Assemblyman Neil Cohen, to move this initiative forward.”